Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy
Year: 2026
Type: article
Abstract: Genetic pain loss disorders represent a heterogeneous group of rare diseases mainly characterized by defective nociception. Understanding the underlying molecular mechanism is fundamental to improve the treatment of patients affected by these rare disorders. Feline Leukemia Virus Subgroup C Receptor 1 (FLVCR1) is one of the genes previously associated with sensory neuropathy that requires further investigation. Here, we report on two additional patients with novel disease-causing variants in FLVCR1 and introduce a zebrafish model of the disease. The analyses of patient-derived fibroblasts show that distinct FLVCR1 variants compromised all the known functions associated with FLVCR1, thus affecting choline levels, heme biosynthesis and mitochondrial Ca2+ handling. Furthermore, we provide evidence that the alteration of these processes impairs the TCA cycle and OXPHOS, and induces lipid peroxidation. Our data points to the alterations of energetic metabolism as a potential driving pathomechanism in FLVCR1-associated sensory neuropathy. Functional studies of pathogenetic FLVCR1 variants associated with sensory neuropathy reveal that impaired choline uptake, heme biosynthesis, and ER–mitochondria Ca²⁺ transfer result in mitochondrial energetic failure.
Source: Communications Biology
Authors: Francesca Bertino, Diletta Isabella Zanin Venturini, Eleonora Grasso, Joanna Kopecka, Chiara Salio, Barbara Gnutti, Ram Manohar Basnet, Stefania Bellini, Luca Mignani, Boxun Zhao, Felix Kleefeld, Andreas Hentschel, Francesca Magnani, Veronica Fiorito, Raluca Elena Abalai, Livia Metani, Anna Lucia Allocco, Sara Petrillo, Francesco De Giorgio, Giorgia Ammirata, Ettore Salsano, Davide Pareyson, Maja di Rocco, Angela Abicht, Emily McCourt, Rita Horvath, Heike Kölbel, Austin Larson, Andreas Roos, Timothy W. Yu, Dario Finazzi, Chiara Riganti, Emanuela Tolosano, Deborah Chiabrando
Institutions: University of Turin, University of Brescia, Broad Institute, Boston Children's Hospital, Harvard University, Manton Center for Orphan Disease Research, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin, Leibniz Institute for Analytical Sciences - ISAS, University of Pavia, Fondazione IRCCS Istituto Neurologico Carlo Besta, Istituto Giannina Gaslini, LMU Klinikum, Medical Genetics Center, Ludwig-Maximilians-Universität München, University of Cambridge, Essen University Hospital, Stiftung Universitätsmedizin Essen, University of Duisburg-Essen, University of Colorado Anschutz, University of Colorado Denver, Children's Hospital of Eastern Ontario, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,190
Funders: Compagnia di San Paolo, Wellcome Trust, National Institute for Health and Care Research, Department of Health and Social Care, Fondazione Telethon, Evelyn Trust, Associazione Italiana per la Ricerca sul Cancro, Deutsche Gesellschaft für Muskelkranke, Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, Manton Center for Orphan Disease Research, Boston Children's Hospital, Medical Research Council, Addenbrooke's Charitable Trust, Cambridge University Hospitals, European Regional Development Fund, NIHR Cambridge Biomedical Research Centre
Awards: Exploring novel molecular targets in mitochondrial protein synthesis to develop treatments in mitochondrial disease., G139696651, G1686001428, G299057155, G3540216858, G3584577881, G370598735, G426687523, G4866301326, G4993377907, G520375372, G5484725842, Exploring novel molecular targets in mitochondrial protein synthesis to develop treatments in mitochondrial disease., Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases, G5990717379, G6077662935, MRC Strategic Award to establish an International Centre for Genomic Medicine in Neuromuscular Diseases, G6637185184, G6641991021, G6707106261, G6746949437, G6868616705, G692795203, G724433139, G7492172941, G7826725679, G8967934940, G9000334917, Nuclear mechanisms underpinning mitochondrial vulnerability in different cell- types
OpenAlex ID: W7128926628
